Wolverine Trading
PAVM icon

Wolverine Trading’s PAVmed PAVM Stock Holding History

Wolverine Trading’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-497
Closed -$61.4K – 5072
2023
Q4 		$61.4K Buy
497
+464
+1,406% +$54.7K ﹤0.01% 4209
2023
Q3 		$4.36K Buy
+33
New +$5.12K ﹤0.01% 4383
2023
Q2 		– Sell
-50
Closed -$9K – 4756
2023
Q1 		$9K Buy
50
+14
+39% +$2.95K ﹤0.01% 4080
2022
Q4 		$8K Buy
+36
New +$13.6K ﹤0.01% 3825
2022
Q2 		– Sell
-73
Closed -$47K – 5401
2022
Q1 		$47K Sell
73
-55
-43% -$40.9K ﹤0.01% 5091
2021
Q4 		$147K Buy
128
+75
+142% +$163K ﹤0.01% 4904
2021
Q3 		$200K Sell
53
-66
-55% -$208K ﹤0.01% 5350
2021
Q2 		$340K Buy
119
+72
+153% +$170K ﹤0.01% 4240
2021
Q1 		$98K Buy
+47
New +$70.7K ﹤0.01% 5441

Other funds holding PAVM

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's PAVM Position: Q4 2022 in Review

Wolverine Trading sold out of PAVmed (PAVM) in Q4 2022, closing a stake of 32 shares — an estimated $12.1K sold.

Wolverine Trading first reported a position in PAVM in Q1 2021 and held it in 6 quarters. The position peaked at $365K in Q3 2021. 62 funds tracked by Wall St. Rank hold PAVM as of Q4 2022.

  • Wolverine Trading reported no remaining PAVmed position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 32 PAVmed shares in Q4 2022, an estimated $12.1K.
  • Wolverine Trading first reported a position in PAVmed in Q1 2021 and held it in 6 quarters.
  • Wolverine Trading's PAVmed position peaked at $365K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held PAVmed as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.